Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $72.70 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $31.24 | 2 | $0 (2018) |
| Lundbeck LLC | $15.10 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $13.62 | 1 | $0 (2019) |
| Novo Nordisk Inc | $12.74 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $26.36 | 2 | Janssen Pharmaceuticals, Inc ($13.62) |
| 2018 | $46.34 | 3 | Alkermes, Inc. ($31.24) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 03/26/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Neuroscience | ||||||
| 12/12/2018 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: CNS | ||||||
| 08/08/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 88 | $19,178 | $5,376 |
| 2022 | 4 | 93 | 178 | $42,390 | $10,728 |
| 2021 | 5 | 110 | 188 | $39,359 | $10,472 |
| 2020 | 5 | 131 | 267 | $57,346 | $16,398 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 59 | $12,508 | $3,512 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 29 | $6,670 | $1,863 | 27.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 107 | $22,684 | $5,428 | 23.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $8,844 | $2,158 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 25 | $5,750 | $1,819 | 31.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 23 | 24 | $5,112 | $1,323 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 73 | $15,476 | $4,078 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 31 | $7,174 | $2,207 | 30.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 25 | 28 | $5,964 | $1,515 | 25.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $6,030 | $1,477 | 24.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 41 | $4,715 | $1,196 | 25.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 145 | $27,506 | $8,004 | 29.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 21 | 23 | $9,508 | $2,620 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 31 | $7,830 | $2,384 | 30.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 37 | 39 | $7,902 | $2,258 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 29 | $4,600 | $1,131 | 24.6% |
About Dr. John Pogue, MD
Dr. John Pogue, MD is a Psychiatry healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225068695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Pogue, MD has received a total of $72.70 in payments from pharmaceutical and medical device companies, with $26.36 received in 2019. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($72.70).
As a Medicare-enrolled provider, Pogue has provided services to 368 Medicare beneficiaries, totaling 721 services with total Medicare billing of $42,974. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Tyler, TX
- Active Since 07/03/2006
- Last Updated 02/18/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1225068695
Products in Payments
- Aristada 441 mg (Drug) $16.82
- ABILIFY MAINTENA (Drug) $15.10
- Vivitrol 380 mg (Drug) $14.42
- SPRAVATO (Drug) $13.62
- Ozempic (Drug) $12.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Tyler
Gary Wilson, Md, MD
Psychiatry — Payments: $4,403
Chance Mcinnis
Psychiatry — Payments: $4,281
David Danly, Md, MD
Psychiatry — Payments: $4,150
Dr. Douglas Ghrist, M.d, M.D
Psychiatry — Payments: $1,644
Igal Tarash, Do Md Emba, DO MD EMBA
Psychiatry — Payments: $734.11
Phyllis Ramirez, Md, MD
Psychiatry — Payments: $712.87